Merck to invest 9,560 BTC in new Delaware plant to boost US manufacturing \ stacker news ~Construction_and

USD/BTC = $104,614 Block 896,334 TL:DR

April 29 (Reuters) -

U.S. drugmaker Merck (MRK.N), opens new tab said on Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares to deal with President Donald Trump's tariffs.

The new facility will produce biologic drugs and Keytruda, becoming Merck's first in-house U.S. site to make the blockbuster cancer treatment, the company said.

Merck said last week its biggest tariff exposure is through Keytruda and it has enough U.S. inventory for this year. It estimated $200 million in additional costs for the levies implemented to date.

The company expects labs at the new facility to be fully operational by 2028 and produce experimental drugs by 2030.

The new plant would create at least 500 full-time jobs and about 4,000 construction vacancies, the company said.

Merck opened a $1 billion facility at its North Carolina site last month to boost U.S. production.

The Trump administration has been putting pressure on U.S. drugmakers to move their medicine production to the country and announced probes into drug imports that set the stage for levies in the sector.

U.S. drugmakers, including Eli Lilly (LLY.N), opens new tab and Johnson & Johnson (JNJ.N), opens new tab, have recently announced additional investments to boost domestic production amid the tariff threat.

My Thoughts 💭

Only a few months in and the tariffs are having major impact on cap ex spend. Looks like big pharma is playing ball and on shoring production.

95 sats \ 0 replies \ @kurszusz 17h

Thousands of BTC worth of investments here too...and people are crying that "there is no money"...there is money, but it is not distributed properly...and it is not always spent on the right things (I did not mean this investment that it is spent incorrectly)

143 sats \ 0 replies \ @Rothbardian_fanatic 23h

Merck wants to avoid the tariffs on Keytruda, a really high value anti-cancer drug. The tariff on those drugs would make the anti-cancer treatments even more sky-high than they already are. Merck is just lucky that people do not understand that there are other ways to treat cancer. Very effective and cheap ways to do it.